Cargando…

Elucidation of the Pathogenesis of Autoinflammatory Diseases Using iPS Cells

Autoinflammatory diseases are a disease entity caused by the dysregulation of innate immune cells. Typical autoinflammatory diseases are monogenic disorders and often very rare. As a result, there is a relative lack of understanding of the pathogenesis, poor diagnosis and little available treatment....

Descripción completa

Detalles Bibliográficos
Autor principal: Saito, Megumu K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912798/
https://www.ncbi.nlm.nih.gov/pubmed/33535645
http://dx.doi.org/10.3390/children8020094
_version_ 1783656658997608448
author Saito, Megumu K.
author_facet Saito, Megumu K.
author_sort Saito, Megumu K.
collection PubMed
description Autoinflammatory diseases are a disease entity caused by the dysregulation of innate immune cells. Typical autoinflammatory diseases are monogenic disorders and often very rare. As a result, there is a relative lack of understanding of the pathogenesis, poor diagnosis and little available treatment. Induced pluripotent stem (iPS) cells are a new technology being applied to in vitro disease modeling. These models are especially useful for the analysis of rare and intractable diseases including autoinflammatory diseases. In this review, I will provide a general overview of iPS cell models for autoinflammatory diseases and a brief description of the results obtained from individual reports.
format Online
Article
Text
id pubmed-7912798
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-79127982021-02-28 Elucidation of the Pathogenesis of Autoinflammatory Diseases Using iPS Cells Saito, Megumu K. Children (Basel) Review Autoinflammatory diseases are a disease entity caused by the dysregulation of innate immune cells. Typical autoinflammatory diseases are monogenic disorders and often very rare. As a result, there is a relative lack of understanding of the pathogenesis, poor diagnosis and little available treatment. Induced pluripotent stem (iPS) cells are a new technology being applied to in vitro disease modeling. These models are especially useful for the analysis of rare and intractable diseases including autoinflammatory diseases. In this review, I will provide a general overview of iPS cell models for autoinflammatory diseases and a brief description of the results obtained from individual reports. MDPI 2021-02-01 /pmc/articles/PMC7912798/ /pubmed/33535645 http://dx.doi.org/10.3390/children8020094 Text en © 2021 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Saito, Megumu K.
Elucidation of the Pathogenesis of Autoinflammatory Diseases Using iPS Cells
title Elucidation of the Pathogenesis of Autoinflammatory Diseases Using iPS Cells
title_full Elucidation of the Pathogenesis of Autoinflammatory Diseases Using iPS Cells
title_fullStr Elucidation of the Pathogenesis of Autoinflammatory Diseases Using iPS Cells
title_full_unstemmed Elucidation of the Pathogenesis of Autoinflammatory Diseases Using iPS Cells
title_short Elucidation of the Pathogenesis of Autoinflammatory Diseases Using iPS Cells
title_sort elucidation of the pathogenesis of autoinflammatory diseases using ips cells
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912798/
https://www.ncbi.nlm.nih.gov/pubmed/33535645
http://dx.doi.org/10.3390/children8020094
work_keys_str_mv AT saitomegumuk elucidationofthepathogenesisofautoinflammatorydiseasesusingipscells